Repare Therapeutics Inc.
RPTX
$1.42
$0.032.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -179.90% | 9.71% | 13.73% | -2,121.82% | -56.32% |
| Total Depreciation and Amortization | 29.59% | -1.54% | 3.84% | 5.67% | 5.68% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -10.59% | 2.57% | -19.94% | -12.72% | -12.75% |
| Change in Net Operating Assets | 82.12% | 74.53% | 72.71% | -11.37% | -3,099.95% |
| Cash from Operations | -40.83% | 39.88% | 39.93% | -945.96% | -5,622.91% |
| Capital Expenditure | -- | -- | -321.11% | -362.79% | -147.97% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 49.64% | -38.15% | -37.33% | 128.46% | 136.14% |
| Cash from Investing | 53.04% | -36.61% | -37.97% | 128.18% | 135.22% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -69.40% | -35.63% | -28.38% | -13.87% | -23.57% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -69.40% | -35.63% | -28.38% | -13.87% | -23.57% |
| Foreign Exchange rate Adjustments | -289.47% | -627.27% | 113.77% | 83.52% | 95.27% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.84% | 44.98% | 43.90% | 77.71% | 90.07% |